MAN1A1
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA
Also known as: MA1A1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P33908
- Gene
- MAN1A1
- Ensembl
- ENSG00000111885
- Chromosome
- 6
- Canonical length
- 653 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
This gene encodes a class I mammalian Golgi 1,2-mannosidase which is a type II transmembrane protein. This protein catalyzes the hydrolysis of three terminal mannose residues from peptide-bound Man(9)-GlcNAc(2) oligosaccharides and belongs to family 47 of glycosyl hydrolases. [provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
653 residues, UniProt reviewed canonical sequence.
>P33908|MAN1A1
1 MPVGGLLPLF SSPAGGVLGG GLGGGGGRKG SGPAALRLTE KFVLLLVFSA FITLCFGAIF
61 FLPDSSKLLS GVLFHSSPAL QPAADHKPGP GARAEDAAEG RARRREEGAP GDPEAALEDN
121 LARIRENHER ALREAKETLQ KLPEEIQRDI LLEKKKVAQD QLRDKAPFRG LPPVDFVPPI
181 GVESREPADA AIREKRAKIK EMMKHAWNNY KGYAWGLNEL KPISKGGHSS SLFGNIKGAT
241 IVDALDTLFI MEMKHEFEEA KSWVEENLDF NVNAEISVFE VNIRFVGGLL SAYYLSGEEI
301 FRKKAVELGV KLLPAFHTPS GIPWALLNMK SGIGRNWPWA SGGSSILAEF GTLHLEFMHL
361 SHLSGNPIFA EKVMNIRTVL NKLEKPQGLY PNYLNPSSGQ WGQHHVSVGG LGDSFYEYLL
421 KAWLMSDKTD LEAKKMYFDA VQAIETHLIR KSSSGLTYIA EWKGGLLEHK MGHLTCFAGG
481 MFALGADAAP EGMAQHYLEL GAEIARTCHE SYNRTFMKLG PEAFRFDGGV EAIATRQNEK
541 YYILRPEVME TYMYMWRLTH DPKYRKWAWE AVEALENHCR VNGGYSGLRD VYLLHESYDD
601 VQQSFFLAET LKYLYLIFSD DDLLPLEHWI FNSEAHLLPI LPKDKKEVEI REELocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAN1A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 145 nTPM
Expression across tissuesHPA
Tissue
- liver: 145 nTPM
- adipose tissue: 96 nTPM
- placenta: 75 nTPM
- small intestine: 66 nTPM
- kidney: 62 nTPM
- urinary bladder: 53 nTPM
Single-cell type
- macrophages: 846 nCPM
- hematopoietic stem cells: 809 nCPM
- plasma cells: 755 nCPM
- thymocytes: 638 nCPM
- neutrophils: 567 nCPM
- lymphatic endothelial cells: 557 nCPM
Immune cell
- basophil: 4.3 nTPM
- plasmacytoid DC: 2.9 nTPM
- MAIT T-cell: 2.3 nTPM
- neutrophil: 1.9 nTPM
- eosinophil: 1.1 nTPM
- gdT-cell: 1.1 nTPM
Brain region
- basal ganglia: 29 nTPM
- cerebral cortex: 22 nTPM
- hypothalamus: 22 nTPM
- hippocampal formation: 20 nTPM
- white matter: 16 nTPM
- midbrain: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.11
- gnomAD missense Z
- 1.51
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate metabolic process
- ERAD pathway
- Golgi apparatus N-glycan mannose trimming
- protein targeting to ER
- mannose trimming involved in glycoprotein ERAD pathway
Molecular functions
- calcium ion binding
- mannosyl-oligosaccharide 1,2-alpha-mannosidase activity
- mannosidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAN1A1 as an antibody target. Whether an autoantibody or antibody against MAN1A1 could matter depends on whether native MAN1A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAN1A1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAN1A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...